Strides Pharma Science announced that its step-down completely owned subsidiary, Strides Pharma Global Pte. Ltd, Singapore, has acquired popularity of Prednisone Tablets USP, 2.Five mg and 5 mg from america Food & Drug Administration (USFDA). The product is bioequivalent and therapeutically equivalent to the Reference Listed Drug (RLD), Deltasone Tablets, 2.Five mg and five mg, of Pharmacia and Upjohn Co. According to IQVIA MAT September 2020 information, the United States marketplace for Prednisone Tablets USP, 2.Five mg and 5 mg is approximately US$ 30 Mn. The product could be manufactured at the organization’s flagship facility at Bengaluru and may be marketed by using Strides Pharma Inc. In the US market.
The corporation has 127 cumulative ANDA filings with USFDA of which ninety three ANDAs had been accepted and 34 are pending approval.
Bazaarinformation team has many years of experience, covering the physical and future commodities markets with prominent commodity & equity trading advising which shines further with extensive network to get research from ground levels to generate proper reporting and movements. We are able to get evens out of odds in volatile markets and stockings. ...
